Correlation Between Circuit Fabology and Corvus Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Circuit Fabology and Corvus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Circuit Fabology and Corvus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Circuit Fabology Microelectronics and Corvus Pharmaceuticals, you can compare the effects of market volatilities on Circuit Fabology and Corvus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Circuit Fabology with a short position of Corvus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Circuit Fabology and Corvus Pharmaceuticals.

Diversification Opportunities for Circuit Fabology and Corvus Pharmaceuticals

0.78

Correlation Coefficient

Circuit Fabology  Corvus Pharmaceuticals

Poor diversification

The 3 months correlation between Circuit and Corvus is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Circuit Fabology Microelectron and Corvus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Corvus Pharmaceuticals and Circuit Fabology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Circuit Fabology Microelectronics are associated (or correlated) with Corvus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Corvus Pharmaceuticals has no effect on the direction of Circuit Fabology i.e., Circuit Fabology and Corvus Pharmaceuticals go up and down completely randomly.

Pair Corralation between Circuit Fabology and Corvus Pharmaceuticals

Assuming the 90 days trading horizon Circuit Fabology Microelectronics is expected to generate 0.74 times more return on investment than Corvus Pharmaceuticals. However, Circuit Fabology Microelectronics is 1.36 times less risky than Corvus Pharmaceuticals. It trades about -0.02 of its potential returns per unit of risk. Corvus Pharmaceuticals is currently generating about -0.07 per unit of risk. If you would invest  6,739  in Circuit Fabology Microelectronics on September 4, 2024 and sell it today you would lose (181.00) from holding Circuit Fabology Microelectronics or give up 2.69% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	95.45%
Values	Daily Returns

Circuit Fabology Microelectron  vs.  Corvus Pharmaceuticals

Circuit Fabology Mic

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Circuit Fabology Microelectronics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Circuit Fabology sustained solid returns over the last few months and may actually be approaching a breakup point.

Corvus Pharmaceuticals

Risk-Adjusted Performance

19 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Corvus Pharmaceuticals are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Corvus Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Circuit Fabology and Corvus Pharmaceuticals

The main advantage of trading using opposite Circuit Fabology and Corvus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Circuit Fabology position performs unexpectedly, Corvus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Corvus Pharmaceuticals will offset losses from the drop in Corvus Pharmaceuticals' long position.

The idea behind Circuit Fabology Microelectronics and Corvus Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.